Adverum Biotechnologies

ADVM

5.60

+0.45

+8.7%

Please Login or Register

Login|Register FREE

Stock Price
Open: 5.22
Prev. Close: 5.15
Low/Hi: 5.10 - 5.75
52-Week: 2.40 - 5.30
Volumes
Equity: 907,454
90-Day Avg: 509,711
Option: 484
90-Day Avg: 138
Volatility
Todays Stock Vol: 112.4
20-Day (HV): 79.8
52-Week (HV): 69.0
30-Day IV: 78.5 +14.4
IV Pct Rank: 31% Subdued
Fundamental
Div. Yield:
Earnings: 5-Mar (Est.)
P/E Ratio:
Market Cap: 232.0 M
Short Int Pct: 0.0%
Pct Held By Inst.: 38.7%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ADVM Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
Barclays Gene Editing & Gene Therapy Summit Nov 30, 2017
29th Annual Piper Jaffray Healthcare Conference Nov 28, 2017
Jefferies Gene Technology Summit Conference Oct 12, 2017
Chardan Gene Therapy Conference Oct 10, 2017
Cell & Gene Meeting on the Mesa Oct 5, 2017
Jefferies Global Healthcare Conference Jun 7, 2017
ARVO and ASGCT 2017 Annual Meetings May 10, 2017
ARM 5th Annual Cell & Gene Therapy Investor Day Apr 27, 5:00 PM
29th Annual ROTH Conference Mar 13, 10:30 AM
Cowen and Company 37th Annual Health Care Conference Mar 6, 2017
Phacilitate Cell & Gene Therapy World 2017 conference Jan 19, 2017
28th Annual Piper Jaffray Healthcare Conference Nov 30, 4:00 PM New York
Jefferies 2016 London Healthcare Conference Nov 16, 2016
i

London

European Society of Gene and Cell Therapy (ESGCT) meeting Oct 18, 2016 - Oct 21, 2016
i

The Company is presenting data during an oral presentation and two poster sessions.

ARVO 2016 Annual Meeting May 4, 12:00 AM - May 7, 2016 Seattle
Association for Research in Vision and Ophthalmology (ARVO) May 4, 2016 - May 7, 2016 Seattle,
American Society of Gene & Cell Therapy (ASGCT) 19th Annual Meeting May 1, 2016 - May 5, 2016 Washington, DC.
Regenerative Medicines 4th Annual Cell and Gene Therapy Investor Day Mar 22, 2016 New York
i

Paul B. Cleveland, president and chief executive officer of Avalanche, will present

Cowen Health Care Conference Mar 9, 2016
Avalanche Biotechnologies Inc Conference Call To Discuss The Science Behind Annapurna Feb 17, 2016
Avalanche Biotechnologies Inc and Annapurna Therapeutics Announce Proposed Merger M&A Call Feb 1, 2016
Association of Geographic Atrophy (GA) and Visual Acuity (VA) with Anti-VEGF Therapy Exposure in the Comparison of Age-Related Macular Degeneration Treatments May 5, 8:30 AM
i

Association of Geographic Atrophy (GA) and Visual Acuity (VA) with Anti-VEGF Therapy Exposure in the Comparison of Age-Related Macular Degeneration Treatments Trial (CATT)

Association for Research in Vision and Ophthalmology(ARVO) 2015 Annual Meeting in Denver May 4, 8:45 AM
i

One-Year Analysis of sFlt-1 and VEGF Proteins and Immunological Markers in the Bodily Fluids of Subjects Participating in the Phase I rAAV.sFlt-1 Trial

American Society of Gene & Cell Therapy (ASGCT) 18th Annual Meeting in New Orleans.

Wait, Before You Leave...

Want to Know More About ADVM Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon